Challenges of integrating economics into epidemiological analysis of and policy responses to emerging infectious diseases.


Journal

Epidemics
ISSN: 1878-0067
Titre abrégé: Epidemics
Pays: Netherlands
ID NLM: 101484711

Informations de publication

Date de publication:
06 2022
Historique:
received: 13 07 2021
revised: 23 04 2022
accepted: 19 05 2022
pubmed: 1 6 2022
medline: 16 6 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

COVID-19 has shown that the consequences of a pandemic are wider-reaching than cases and deaths. Morbidity and mortality are important direct costs, but infectious diseases generate other direct and indirect benefits and costs as the economy responds to these shocks: some people lose, others gain and people modify their behaviours in ways that redistribute these benefits and costs. These additional effects feedback on health outcomes to create a complicated interdependent system of health and non-health outcomes. As a result, interventions primarily intended to reduce the burden of disease can have wider societal and economic effects and more complicated and unintended, but possibly not anticipable, system-level influences on the epidemiological dynamics themselves. Capturing these effects requires a systems approach that encompasses more direct health outcomes. Towards this end, in this article we discuss the importance of integrating epidemiology and economic models, setting out the key challenges which such a merging of epidemiology and economics presents. We conclude that understanding people's behaviour in the context of interventions is key to developing a more complete and integrated economic-epidemiological approach; and a wider perspective on the benefits and costs of interventions (and who these fall upon) will help society better understand how to respond to future pandemics.

Identifiants

pubmed: 35636312
pii: S1755-4365(22)00033-0
doi: 10.1016/j.epidem.2022.100585
pmc: PMC9124042
pii:
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100585

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Références

J Health Econ. 2013 Mar;32(2):440-51
pubmed: 23419635
J Theor Biol. 2014 Dec 21;363:105-17
pubmed: 25111844
J Math Biol. 2005 Aug;51(2):123-43
pubmed: 16012804
BMC Med. 2020 May 7;18(1):124
pubmed: 32375776
Sci Rep. 2021 Feb 4;11(1):3174
pubmed: 33542386
Biosecur Bioterror. 2006;4(4):366-75
pubmed: 17238820
Lancet Public Health. 2020 May;5(5):e271-e278
pubmed: 32251626
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18519-23
pubmed: 25512538
BJPsych Bull. 2021 Dec;45(6):332-338
pubmed: 32475375
Epidemics. 2015 Mar;10:21-5
pubmed: 25843377
Ecohealth. 2014 Dec;11(4):464-75
pubmed: 25233829
J Vocat Behav. 2020 Jun;119:103433
pubmed: 32390654
J R Soc Interface. 2010 Sep 6;7(50):1247-56
pubmed: 20504800
Am J Emerg Med. 2020 Dec;38(12):2753-2755
pubmed: 32402499
Ecohealth. 2020 Jun;17(2):217-221
pubmed: 32350634
Eur J Public Health. 2021 Jul 13;31(3):634-640
pubmed: 33755130
Public Health. 2021 Mar;192:45-48
pubmed: 33631513
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6306-11
pubmed: 21444809
Proc Biol Sci. 2015 Nov 7;282(1818):20150814
pubmed: 26511046
Health Econ. 2016 Nov;25(11):1448-1463
pubmed: 26315327
Risk Anal. 2021 May;41(5):761-770
pubmed: 32677076
Science. 2020 Jul 24;369(6502):379-381
pubmed: 32703868
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20210001
pubmed: 34053252
Front Psychiatry. 2020 Aug 07;11:790
pubmed: 32848952
Trends Ecol Evol. 2001 Jun 1;16(6):295-300
pubmed: 11369107
Proc Math Phys Eng Sci. 2020 Jun;476(2238):20200376
pubmed: 32821237
Nature. 2006 Jul 27;442(7101):448-52
pubmed: 16642006
PLoS One. 2013;8(3):e58249
pubmed: 23526970
Wellcome Open Res. 2020 Apr 23;5:75
pubmed: 33709037
J Econ Dyn Control. 2015 Feb;51:166-179
pubmed: 27642202
Ecohealth. 2018 Jun;15(2):244-258
pubmed: 29786132
Health Econ. 2010 Nov;19(11):1345-60
pubmed: 19816886
Child Indic Res. 2018;11(6):1951-1965
pubmed: 30524519
Proc Natl Acad Sci U S A. 2021 Apr 20;118(16):
pubmed: 33820846

Auteurs

Ciara Dangerfield (C)

Isaac Newton Institute for Mathematical Sciences, University of Cambridge, United Kingdom. Electronic address: ced57@cam.ac.uk.

Eli P Fenichel (EP)

Yale School of Environment, United States.

David Finnoff (D)

Department of Economics, University of Wyoming, United States.

Nick Hanley (N)

Institute of Biodiversity, Animal Health & Comparative Medicine, University of Glasgow, United Kingdom.

Shaun Hargreaves Heap (S)

Department of Political Economy, Kings College London, United Kingdom.

Jason F Shogren (JF)

Department of Economics, University of Wyoming, United States.

Flavio Toxvaerd (F)

Faculty of Economics, University of Cambridge, United Kingdom; Centre for Economic Policy Research, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH